Related Experiment Video
Updated: Jul 1, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
MFA-DTI: Drug-target interaction prediction based on multi-feature fusion adopted framework
Siqi Chen1, Minghui Li2, Ivan Semenov3
1School of Information Science and Engineering, Chongqing Jiaotong University, Chongqing, 400074, China.
Methods (San Diego, Calif.)
|March 2, 2024
Summary
Predicting drug-target interactions (DTI) is crucial for drug discovery. A new deep learning framework, MFA-DTI, effectively integrates multiple data types to improve DTI prediction accuracy.
Area of Science:
- Computational biology
- Bioinformatics
- Drug discovery
Background:
- Drug-target interactions (DTI) are vital for drug discovery and repositioning.
- Traditional experimental methods for DTI identification are costly and time-consuming.
- Computational methods, especially deep learning, have advanced DTI prediction but face limitations with individual data types and sparse interaction data.
Purpose of the Study:
- To propose a novel deep learning framework, MFA-DTI (Multi-feature Fusion Adopted framework for DTI), for accurate drug-target interaction prediction.
- To address limitations of existing methods in handling diverse data sources and sparse DTI data.
- To enhance the efficiency and accuracy of computational drug discovery pipelines.
Main Methods:
- Developed MFA-DTI, a framework with three modules: interaction graph learning, chemical structure learning, and feature fusion.
- Interaction graph learning module processes network data to generate interaction vectors.
- Chemical structure learning module extracts features from molecular structures.
- Fusion module integrates features for final DTI prediction.
Main Results:
- MFA-DTI demonstrated high effectiveness across six public datasets under various experimental settings.
- The proposed method significantly outperformed existing state-of-the-art DTI prediction techniques.
- The framework successfully leveraged multiple information sources for improved prediction accuracy.
Conclusions:
- MFA-DTI offers a robust and effective approach for predicting drug-target interactions.
- The multi-feature fusion strategy enhances prediction performance, particularly for sparse DTI data.
- This framework represents a significant advancement in computational drug discovery and development.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Quantitative Aspects of Drug-Receptor Interaction
979
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
979
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K

